These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30472429)

  • 1. Artificial intelligence in drug development: present status and future prospects.
    Mak KK; Pichika MR
    Drug Discov Today; 2019 Mar; 24(3):773-780. PubMed ID: 30472429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
    Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
    Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good machine learning practices: Learnings from the modern pharmaceutical discovery enterprise.
    Makarov V; Chabbert C; Koletou E; Psomopoulos F; Kurbatova N; Ramirez S; Nelson C; Natarajan P; Neupane B
    Comput Biol Med; 2024 Jul; 177():108632. PubMed ID: 38788373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential applications of artificial intelligence in drug discovery and development.
    Farghali H; Kutinová Canová N; Arora M
    Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing health care via artificial intelligence: From concept to clinic.
    Sandeep Ganesh G; Kolusu AS; Prasad K; Samudrala PK; Nemmani KVS
    Eur J Pharmacol; 2022 Nov; 934():175320. PubMed ID: 36220360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
    Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
    Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design.
    Vora LK; Gholap AD; Jetha K; Thakur RRS; Solanki HK; Chavda VP
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study on the Application and Use of Artificial Intelligence to Support Drug Development.
    Lamberti MJ; Wilkinson M; Donzanti BA; Wohlhieter GE; Parikh S; Wilkins RG; Getz K
    Clin Ther; 2019 Aug; 41(8):1414-1426. PubMed ID: 31248680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.
    Gautam V; Gaurav A; Masand N; Lee VS; Patil VM
    Mol Divers; 2023 Apr; 27(2):959-985. PubMed ID: 35819579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AI-Driven Enhancements in Drug Screening and Optimization.
    Serghini A; Portelli S; Ascher DB
    Methods Mol Biol; 2024; 2714():269-294. PubMed ID: 37676604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revolutionizing Pharmaceutical Industry: The Radical Impact of Artificial Intelligence and Machine Learning.
    Chhina A; Trehan K; Saini M; Thakur S; Kaur M; Shahtaghi NR; Shivgotra R; Soni B; Modi A; Bakrey H; Jain SK
    Curr Pharm Des; 2023; 29(21):1645-1658. PubMed ID: 37550904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revolutionizing pharmacokinetics: the dawn of AI-powered analysis.
    Ghayoor A; Kohan HG
    J Pharm Pharm Sci; 2024; 27():12671. PubMed ID: 38433887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
    Qi X; Zhao Y; Qi Z; Hou S; Chen J
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborations of Industry, Academia, Research and Application Improve the Healthy Development of Medical Imaging Artificial Intelligence Industry in China.
    Xiao Y; Liu SY
    Chin Med Sci J; 2019 Jun; 34(2):84-88. PubMed ID: 31315748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence in drug discovery and development.
    Paul D; Sanap G; Shenoy S; Kalyane D; Kalia K; Tekade RK
    Drug Discov Today; 2021 Jan; 26(1):80-93. PubMed ID: 33099022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry's Views.
    Mayer M; Canedo A; Dinh T; Low M; Ortiz A; Garay C
    Ther Innov Regul Sci; 2019 Nov; 53(6):759-766. PubMed ID: 30522348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AI could threaten pharmaceutical patents.
    Heuer L
    Nature; 2018 Jun; 558(7711):519. PubMed ID: 29950627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.